JAGUAR HEALTH, INC. Shares Authorized
JAGUAR HEALTH, INC. (JAGX) had Shares Authorized of 150.00 million shares as of 2018-05-18, per its 10-K filed 2019-04-10.
Discontinued › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2019-04-10
- 2018-05-18: Common Stock, Shares Authorized 150.00M shares.
- 2018-03-12: Common Stock, Shares Authorized 500.00M shares.
- 2018-03-11: Common Stock, Shares Authorized 250.00M shares.
- 2017-07-31: Common Stock, Shares Authorized 250.00M shares; Common Stock, Shares Authorized as first filed 50.00M shares.
| Period end | Common Stock, Shares Authorized | Common Stock, Shares Authorized as first filed |
|---|---|---|
| 2018-05-18 | 150.00M shares 10-K · filed 2019-04-10 | |
| 2018-03-12 | 500.00M shares 10-K · filed 2019-04-10 | |
| 2018-03-11 | 250.00M shares 10-K · filed 2019-04-10 | |
| 2017-07-31 | 250.00M shares 10-Q · filed 2018-05-15 | 50.00M shares 10-Q · filed 2017-08-09 |
| 2017-06-30 | 50.00M shares 10-Q · filed 2017-08-09 | |
| 2017-03-31 | 50.00M shares 10-Q/A · filed 2017-06-23 | |
| 2016-12-31 | 50.00M shares 10-Q · filed 2017-08-09 | |
| 2016-09-30 | 50.00M shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 50.00M shares 10-Q · filed 2016-08-15 | |
| 2016-03-31 | 50.00M shares 10-Q · filed 2016-05-10 | |
| 2015-12-31 | 50.00M shares 10-K · filed 2017-02-15 | |
| 2015-09-30 | 50.00M shares 10-Q · filed 2015-11-13 | |
| 2015-06-30 | 50.00M shares 10-Q · filed 2015-08-13 | |
| 2015-05-18 | 50.00M shares 10-Q · filed 2015-11-13 | |
| 2015-05-13 | 50.00M shares 10-Q · filed 2015-11-13 | |
| 2015-03-31 | 15.00M shares 10-Q · filed 2015-06-26 | |
| 2014-12-31 | 15.00M shares 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |